Bradley M Turner (David G Hicks)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Clinical Evaluation

Epidermal Growth Factor Receptor

Top Venues

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Cancer medicine

Biotechnic & histochemistry : official publication of the Biological Stain Commission

This page only lists publications with an associated author ORCID identifier.

Publications

Bradley M Turner, Bradley M Turner
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicine. Biotechnic & histochemistry : official publication of the Biological Stain Commission (2024)
Brian S Finkelman, Huina Zhang, David G Hicks, Bradley M Turner
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations. Cancers 15 (3) (2023)
Bradley M Turner, Brian S Finkelman, David G Hicks, Numbere Numbereye, Ioana Moisini, Ajay Dhakal, Kristin Skinner, Mary Ann G Sanders, Xi Wang, Michelle Shayne, Linda Schiffhauer, Hani Katerji, Huina Zhang
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX ® Testing. Cancers 15 (3) (2023)
Brian S Finkelman, Huina Zhang, David G Hicks, Bradley M Turner
The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations. Cancers 15 (3) (2023)
Bradley M Turner, Brian S Finkelman, David G Hicks, Numbere Numbereye, Ioana Moisini, Ajay Dhakal, Kristin Skinner, Mary Ann G Sanders, Xi Wang, Michelle Shayne, Linda Schiffhauer, Hani Katerji, Huina Zhang
The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX ® Testing. Cancers 15 (3) (2023)
Huina Zhang, Hani Katerji, Bradley M Turner, William Audeh, David G Hicks
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (8) (2022)
Armen Soukiazian, David G Hicks, Bradley M Turner
Reconsidering "low-risk" criteria for breast cancer recurrence in hormone positive patients. The breast journal 25 (3) (2019)
Bradley M Turner, Mary Ann Gimenez-Sanders, Armen Soukiazian, Andrea C Breaux, Kristin Skinner, Michelle Shayne, Nyrie Soukiazian, Marilyn Ling, David G Hicks
Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26. Cancer medicine 8 (9) (2019)